IXICO: Blood test deal gives small-cap a shot in the arm A pair of new contracts has given a lift to IXICO PLC (LSE:IXI, OTC:PHYOF), the London-listed neuroscience data specialist whose…
IXICO strikes key data deal with Alzheimer’s research group to bolster biomarker capabilities IXICO PLC (LSE:IXI, OTC:PHYOF), the London-based brain imaging company, has expanded its partnership with the Global Alzheimer’s Platform Foundation (GAP)...…
IXICO shares jump as much as 15% as full-year revenues set to beat forecasts Shares in IXICO PLC (LSE:IXI, OTC:PHYOF) rose as much as 15% on Thursday after the neuroscience analytics group said it expects…
IXICO expects 2025 revenues to exceed forecasts as strategy starts to bear fruit IXICO PLC (LSE:IXI, OTC:PHYOF) said on Thursday that it expects full-year revenues to come in ahead of expectations, marking a…
IXICO shares jump 9% after playing key role in FDA-approved Alzheimer’s blood test Shares in IXICO PLC (LSE:IXI, OTC:PHYOF) rose 9% after the neuro-imaging specialist confirmed its involvement in the first FDA-approved blood test…
IXICO supports first US approval of blood test for Alzheimer’s diagnosis IXICO PLC (LSE:IXI, OTC:PHYOF), the neuro-imaging specialist, played a key role in the US approval of a new blood test…
IXICO shares jump as company signals it may exceed expectations for the year Shares in neuroscience analytics firm IXICO PLC (LSE:IXI, OTC:PHYOF) rose 11% on Tuesday after the company said it was well…
IXICO says focused strategy has put it on course to exceed full-year expectations IXICO PLC (LSE:IXI, OTC:PHYOF) said on Tuesday it is on track to meet or exceed expectations for the year, crediting a…
IXICO shares boosted by upbeat trading update IXICO PLC (AIM:IXI, OTC:PHYOF) told investors it expects to report £3.2 million of revenue for the six months to 31…
IXICO offers significant upside now it has strengthened its balance sheet With a stronger balance sheet secured, Cavendish believes IXICO PLC (AIM:IXI, OTC:PHYOF) shares offer significant upside for investors. The med-tech firm,...…
IXICO lands £500k phase II Huntingtons contract IXICO PLC (AIM:IXI, OTC:PHYOF), a neuroscience imaging company, has secured a new contract with a US-based client for a phase…
IXICO up 33% after £5.8m order boost IXICO PLC (AIM:IXI, OTC:PHYOF) shares surged 33% following a positive trading update in which it said it had landed new contract…